Angus Hay
Director @ Kelvin Capital
Dundee, United Kingdom
Angus Hay is a seed investor at Kelvin Capital in Dundee focused on Health Care and Biotechnology. Angus has been involved in the private equity market over the last 10 years as a lead advisor to over 350 technology companies advising on strategy and business model, ensuring their investor ready status. Angus has strong knowledge and significant experience of the private equity market, Scottish Co-Investment partners and the independent venturecapitalists network.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 71%
Last updated:
For AI agents: llms.txt
Industries Angus Hay invests in
Stages Angus Hay invests in
Countries Angus Hay invests in
Investment Focus
Industry
- Health Care 2 (14%)
- Biotechnology 2 (14%)
- Renewable Energy 2 (14%)
- Apps 1 (7%)
- Energy 1 (7%)
Stage
- Seed 6 (43%)
- Funding Round 2 (14%)
- Series A 1 (7%)
Country
- United Kingdom 7 (50%)
- United States 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Chromacity
|
Chromacity Lasers is a spin-out from Heriot-Watt University, one of the UK’s leading technical universities with a focus on photonics. Their founding team has over 40 years’ experience in ultrafast lasers and fiber lasers. They have developed wavelength tunable femtosecond lasers from the ultraviolet (400 nm) to the mid-infrared (> 6 µm) forindustrial and scientific applications in fluorescence microscopy, gas spectroscopy, laser material processing and semiconductor engineering.Robust, patent-pending femtosecond fiber-laser technology underpins every product, delivering reliable, turn-key performance. But they don’t stop there: their embedded web server provides a uniquely simple control interface, allowing wireless operation from any laptop, tablet or smartphone.Their focus is on manufacturing femtosecond lasers for life-sciences applications. In parallel with these core products, they work with systems manufacturers to provide custom OEM femtosecond and picosecond lasers optimized for specific applications in engineering and materials processing. They can provide combinations of pulse repetition rate, energy and wavelength not available from any other manufacturers. | $1.3M / Seed / Jul 31, 2024 | |
Innovatium
|
Innovatium is a technology company that focuses on renewable energy. | $1.2M / Seed / Mar 21, 2022 | |
|
Chromacity
|
Chromacity Lasers is a spin-out from Heriot-Watt University, one of the UK’s leading technical universities with a focus on photonics. Their founding team has over 40 years’ experience in ultrafast lasers and fiber lasers. They have developed wavelength tunable femtosecond lasers from the ultraviolet (400 nm) to the mid-infrared (> 6 µm) forindustrial and scientific applications in fluorescence microscopy, gas spectroscopy, laser material processing and semiconductor engineering.Robust, patent-pending femtosecond fiber-laser technology underpins every product, delivering reliable, turn-key performance. But they don’t stop there: their embedded web server provides a uniquely simple control interface, allowing wireless operation from any laptop, tablet or smartphone.Their focus is on manufacturing femtosecond lasers for life-sciences applications. In parallel with these core products, they work with systems manufacturers to provide custom OEM femtosecond and picosecond lasers optimized for specific applications in engineering and materials processing. They can provide combinations of pulse repetition rate, energy and wavelength not available from any other manufacturers. | $1.7M / Seed / Aug 11, 2021 | |
ProFactor Pharma
|
Haemophilia is an X-linked genetic disease associated with the dysfunction of the biological cascade leading to blood clotting. Coagulation factors are vital to the functioning of the mechanism that the human body uses to protect and repair itself from physical injury, by the formation of blood clots to seal ruptured blood vessels. Haemophiliapatients have a reduced capacity to stop bleeding and are prone to bleeding internally, into joints and organs, and often require hospitalisation 3-4 times per year. Without proper treatment, haemophiliacs typically die from organ failure in their teens. | $2.5M / Sep 30, 2019 | |
QED Naval
|
QED Naval is a naval architecture consultancy that is focused on the development of the marine renewable energy industry and the vessel requirements for deployment of offshore wind, wave and tidal devices.QED Naval alongside its collaborations also support the development of port and near shore infrastructure required to deploy marinerenewables such as quays, breakwaters and pontoons. | $196K / Seed / Jun 01, 2019 | |
ScotBio
|
ScotBio is an exciting biotech company based in Scotland that produces natural, clean label ingredients for the food, beverage, nutrition, textiles, cosmetic and pharmaceuticals sectors. The company grows algae indoors, in closed hygienic vessels. We produce natural blue pigments, alternative protein, and carotenoids. | $3M / Seed / Nov 26, 2018 | |
|
QED Naval
|
QED Naval is a naval architecture consultancy that is focused on the development of the marine renewable energy industry and the vessel requirements for deployment of offshore wind, wave and tidal devices.QED Naval alongside its collaborations also support the development of port and near shore infrastructure required to deploy marinerenewables such as quays, breakwaters and pontoons. | $643K / Seed / Mar 28, 2018 | |
|
QED Naval
|
QED Naval is a naval architecture consultancy that is focused on the development of the marine renewable energy industry and the vessel requirements for deployment of offshore wind, wave and tidal devices.QED Naval alongside its collaborations also support the development of port and near shore infrastructure required to deploy marinerenewables such as quays, breakwaters and pontoons. | $223K / Seed / Mar 22, 2017 | |
|
ScotBio
|
ScotBio is an exciting biotech company based in Scotland that produces natural, clean label ingredients for the food, beverage, nutrition, textiles, cosmetic and pharmaceuticals sectors. The company grows algae indoors, in closed hygienic vessels. We produce natural blue pigments, alternative protein, and carotenoids. | $643K / Seed / Mar 16, 2017 | |
Midrive
|
At Midrive, they want to make first-time driving better for everyone. The old way of doing things is broken. 53% of learners fail their first test. Of those who pass, 1 in 5 crash in the first 6 months. That’s unacceptable.Their technology helps learners find top-rated instructors and access pay-as-you-go insurance, so they can pass-first timeand ultimately become safer drivers.Since launch, over 300,000 young people in the UK have used their apps, data and tech to gain their independence. They growing quickly and are now available in over 100 towns and cities in the UK, expanding to a new one each week. Recently they were named #19 in the Startup 100, the annual ranking of the most game-changing and exciting new businesses launched in the last three years. They were also named 'Digital Business of the Year' by the Federation of Small Businesses in 2017. | $2.5M / Series A / Dec 23, 2016 | |
| See all 14 investments → | |||
Co-Investors
About Kelvin Capital
Kelvin Capital was founded in 2009 and has since raised a total of over £50million into 28 portfolio companies. We invest venture capital in revenue generating growth companies which have the potential to deliver significant return to their investors. They also invest in companies that require capital to grow their business. For the right companywith the right team, Kelvin Capital provides the investment and the support needed to deliver the true potential of their business.The Kelvin Capital team has a combined 30 years experience of working with new businesses and understands both the challenges and opportunities, which will be encountered during the high growth phase. The team has built up extensive networks, which will be made available to assist and support the portfolio businesses. Kelvin Capital will actively promote the portfolio businesses through its website and social media activities raising their awareness and profile. The entire Kelvin Capital team is focused on the success of their portfolio of businesses.
Kelvin Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Angus Hay
Director
|
|||
John McNicol
Founder and Director
|
|||
Susie Fisher
Investment Director
|
|||
Hayley Leitch
Investment Administrator; Investment Administrator
|
|||
Lynn Hall
Marketing Manager
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Angus Hay invest in?
Angus Hay invests primarily in Health Care, Biotechnology and Renewable Energy startups, most often at Seed and Funding Round stage. Most of the 14 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Angus Hay last invest?
The most recent investment recorded for Angus Hay closed in Jul 2024. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
